The following is an edited excerpt.
Myriad Genetics’s Australian court victory recognizing its ownership of patents for genes linked to cancer risks will be appealed by a group representing cancer patients.
Cancer Voices Australia and Yvonne D’Arcy, a Brisbane resident diagnosed with breast cancer, sued in 2010 to stop Myriad and Genetic Technologies Ltd. from patenting an isolated DNA associated with an increased risk of breast and ovarian cancers, according to Maurice Blackburn Lawyers. The firm said it has filed the appeal in the Federal Court of Australia today.
Share this article
“We intend to continue the challenge to the monopoly created by the patent held by Myriad,” said Rebecca Gilsenan, a lawyer at Maurice Blackburn.
Read the full article here: Myriad Genetics Win on Gene Patent Ownership Is Appealed
